Three of Seattle’s top scientific institutions are launching a nearly $95 million research initiative that will generate data and train AI models to design proteins and genes that don’t exist in nature — sharing the results freely to help others develop new medicines and materials.

The initiative, called AI BioDesign, brings together the Allen Institute, the University of Washington and Fred Hutch Cancer Center, with funding from the Fund for Science and Technology (FFST), created by the estate of Microsoft co-founder Paul Allen.

AI BioDesign is led by David Baker, the UW biochemist who won the 2024 Nobel Prize in Chemistry for using computers…

Read the full article at GEEKWIRE.COM